Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain

Pharmacology Biochemistry and Behavior

Volumn 88, Issue 4, 2008, Pages 511-522

  Bishnoi, Mahendra ^a   Chopra, Kanwaljit ^b   Kulkarni, Shrinivas K ^a,b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Curcumin; Neuroleptic induced; Supersensitivity; Tardive dyskinesia

Indexed keywords

ANTIOXIDANT; CATALASE; CURCUMIN; DOPAMINE; GLUTATHIONE; HALOPERIDOL; LIPID; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SUPEROXIDE DISMUTASE;

ANALYTICAL PARAMETERS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CATECHOLAMINE METABOLISM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; CURCUMA LONGA; DOPAMINE METABOLISM; DOSE RESPONSE; DRUG EFFECT; HYPERKINESIA; LIPID PEROXIDATION; LOCOMOTION; MALE; MASTICATION; NEUROCHEMISTRY; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SEROTONIN METABOLISM; STEREOTYPY; TARDIVE DYSKINESIA; TONGUE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTI-DYSKINESIA AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN CHEMISTRY; CATALASE; CURCUMA; CURCUMIN; DYSKINESIA, DRUG-INDUCED; GLUTATHIONE; HALOPERIDOL; LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

ANIMALIA; CURCUMA LONGA; RATTUS;

EID: 37249010259     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.10.009     Document Type: Article

References (61)

1. Abilio V.C., Araujo C.C.S., Bergamo M., Calvente P., and Ribeiro R.A. Vitamin E attenuates reserpine induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio enhancement in rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 109-114
2. Abilio V.C., Silvr R.H., Carvalho R.C., Grassl C., Calzavara M.B., and Registro S. Important role of striatal catalase I nagging and reserpine induced oral dyskinesia. Neuropharmacology 47 (2004) 263-272
3. Andreassen O.A., and Jorgensen H.A. GM1 ganglioside attenuates the development of vacuous chewing movements induced by long term haloperidol treatment of rats. Psychopharmacology 116 (1994) 517-522
4. Andreassen O.A., and Jorgensen H.A. Neurotoxicity associated with neuroleptics induced oral dyskinesia in rats, implications for tardive dyskinesia. Prog Neurobiol 65 (2000) 525-531
5. Andreassen O.A., Ferrante R.J., Beal M.F., and Jorgensen H.A. Oral dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionicacid. Neuroscience 87 3 (1998) 639-648
6. Araujo C.A.C., and Leon L.L. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96 5 (2001) 723-728
7. Balasubramanyam M., Koteswari A.A., Kumar R.S., Monickaraj S.F., Maheswari J.U., and Mohan V. Curcumin induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 28 (2003) 715-721
8. Bilmen J.G., Khan S.Z., Javed M.H., and Michelangeli F. Inhibition of SERCA calcium pumps by curcumin. Eur J Biochem 268 (2001) 6318-6327
9. Bishnoi M., Chopra K., and Kulkarni S.K. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur J Pharmacol 552 1-3 (2006) 55-66
10. Bishnoi M., Kumar A., Chopra K., and Kulkarni S.K. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Indian J Exp Biol 45 2 (2007) 175-179
11. Bishnoi M., Chopra K., and Kulkarni S.K. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia. Methods Find Exp Clin Pharmacol 29 3 (2007) 211-216
12. Burger M.B.E., Alves A., Callegari L., Athayde F.R., and Zeni G. Ebselen attenuates rerserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 135-140
13. Burger M.B.E., Fachineto R., Alves A., Callegari L., and Rocha J.B.T. Acute reserpine and sub-chronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res 1031 2 (2005) 202-210
14. Burger M.B.E., Fachineto R., Zeni G., and Rocha J.B.T. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81 (2005) 608-615
15. Burnet P.W., Chen C.P., McGowan S., Franklin M., and Harrison P.J. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73 2 (1996) 531-540
16. Cadet J.L., Lohr J.B., and Jeste D.V. Free radicals and tardive dyskinesia. Trends Neurosci 9 (1986) 107-108
17. Cahir M., Mawhinney T., and King D.J. Differential region specific regulation of central alpha1-adrenoceptor binding following chronic haloperidol and clozapine administration in rat. Psychopharmacology 172 (2004) 196-201
18. Calvente P.R., Araujo C.C., Bergamo M., Abilio V.C., D'Almeida V., Ribeiro Rde A., et al. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats. Prog Neuropsychopharmacol Biol Psychiatry 26 2 (2002) 401-405
19. Campos S.C.G., Moreira D.A.C., Silva Nunes T.D., and Colepicolo P. Oxidative stress in alcohol induced rat parotid sialadenosis. Arch Oral Biol (2005) 50661-50668
20. Cara D.B., Dusticier N., Forni C., Lievens J.C., and Daszuta A. Serotonin depletion produces long lasting increase in striatal glutamatergic transmission. J Neurochem 78 (2001) 240-248
21. Casey D.E. Tardive dyskinesia - pathophysiology and animal models. J Clin Psychiat 61 (2000) 5-9
22. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 9 (2003) 161-168
23. Church W.H. Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors. J Undergrad Neurosci Educ 3 2 (2005) A36-A41 [Spring]
24. Creese I., Burt D.R., and Snyder S.H. Dopamine receptor binding predicts and clinical pharmacological potencies of antischizophrenic drugs. Science 192 (1976) 481-483
25. Dyer J.L., Bilmen J.G., Khan S.Z., Hawtin S.R., Wheatley S.R., Javed M.U., et al. Curcumin: a new cell permeant inhibitor of inositol 1,4,5-triphosphate receptors. Cell Calcium 31 (2002) 45-52
26. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophy 82 (1959) 70-77
27. Grimm J.W., Kruzich P.J., and See E. Emergence of oral and locomotor activity in chronic haloperidol treated rats following cortical N-methyl-d-aspartate stimulation. Pharmacol Biochem Behav 60 (1998) 167-173
28. Ichikawa J., Kuroki T., Dai J., and Meltzer H.Y. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. Eur J Pharmacol 351 2 (1998) 163-171 [Jun 19]
29. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus maze for dissociation of amnesic and behavioural effects of drugs in mice. Eur J Pharmacol 1991 (1994) 71-76
30. Klawans H.L., and Rubovits R. An experimental model of tardive dyskinesia. J Neural Trans 33 (1972) 235-246
31. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophy 186 (1978) 189-195
32. Kulkarni S.K. Handbook of Experimental Pharmacology. IIIrd Edition (1999), Vallabh Prakashan, New Delhi 119
33. Kumarguruparam R., Kabalimoorty J., and Nagini S. Co-relation of tissue lipid peroxidation and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 38 (2005) 154-158
34. Lau Y.S., Petroske E., Meredith G.E., and Wang J.Q. Elevated neuronal nitric oxide synthase expression in chronic haloperidol treated rats. Neuropharmacology 45 3 (2003) 986-994
35. Lohr J.B., Kuczenski R., and Niculescu A.B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17 1 (2003) 47-62
36. Lowry O.H., Rosenbrought N.J., Farr A.L., and Randall R.J. Protein measurements with the folin-phenol reagent. J Biol Chem 193 (1951) 265-275
37. Luck H. Catalase spectrophotometric method. In: Bergmeyer H.U. (Ed). Methods in Enzymatic analysis (1963), Academic press, New York 885-893
38. Naidu P.S., and Kulkarni S.K. Excitatory mechanisms in neuroleptic induced vacuous chewing movements: possible involvement of calcium and nitric oxide. Behav Pharmacol 12 (2001) 209-216
39. Naidu P.S., and Kulkarni S.K. Possible involvement of prostaglandins in haloperidol induced orofacial Dyskinesia in rats. Eur J Pharmacol 430 2-3 (2001) 295-298
40. Naidu P.S., Singh A., and Kulkarni S.K. Quercetin, a bioflavonoid attenuated haloperidol induced orofacial dyskinesia. Neuropharmacology 44 (2003) 1100-1106
41. Naidu P.S., Singh A., and Kulkarni S.K. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin. Pharmacology 70 2 (2004) 59-67
42. Naidu P.S., Singh A., and Kulkarni S.K. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res 20 2 (2006) 140-146
43. Okamoto T., Yamagishi S., Inagaki Y., Amano S., Koga K., Abe R., et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastin. FASEB J 16 (2002) 1928-1930
44. Panet H., Barzilai A., Daily D., Melamed E., and Offen D. Activation of nuclear transcription factor kappa B (NF-kB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem 77 (2004) 391-398
45. Pantelis C., Stuart G.W., Nelson H.E., Robbins T.W., and Barnes T.R. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry 158 8 (2001) 1276-1285
46. Perry J.C., Vital M.A.B.F., Frussa-Filho R., Tufik S., and Palerma-Neto J. Monosialo gangliosides (GM1) attenuates the behavioural effects of long term haloperidol administration in supersensitive rats. Eur Neuropsychopharmacol 14 (2004) 127-133
47. Quiles J.L., Mesa M.D., Ramirez-Tortosa C.L., Aguilera C.M., Bationo M., Gil A., et al. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46 (2002) 1013-1016
48. Ramirez-Tortosa M.C. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 22 (2002) 1225
49. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine induced learning impairment. Brain Res 799 (1998) 215-219
50. Rodrigo R., Castillo R., Carrasco R., Huerta P., and Moreno M. Diminution of tissue lipid peroxidation in rats is related to the in vitro antioxidant capacity of wine. Life Sci 76 (2005) 889-900
51. Seeman P., Lee T., Chaw-Wong M., and Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
52. Silva R.H., Abílio V.C., Torres-Leite D., Bergamo M., Chinen C.C., Claro F.T., et al. Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice. Behav Brain Res 132 2 (2002) 171-177
53. Singh A., Naidu P.S., and Kulkarni S.K. Possible antioxidant and neuroprotective actions of FK506 in attenuating haloperidol induced orofacial dyskinesia. Eur J Pharmacol 477 (2003) 87-94
54. Sorokin J.E., Giordani B., Mohs R.C., Losonczy M.F., Davidson M., Siever L.J., et al. Memory impairment in schizophrenic patients with tardive dyskinesia. Biol Psychiatry 23 2 (1988) 129-135
55. Teismann P., Kim T., Dong-Kug C., Du-Chu W., Ali N., Hunot S., et al. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. PNAS 100 (2003) 5473-5478
56. Tsai G.C., Golf D.C., Chang R.W., Flood J., Baer L., and Coyle J.T. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155 (1998) 1207-1213
57. Wang T., Pei Z., Zhang W., Liu B., Langenbach R., Lee C., et al. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J 19 9 (2005) 1134-1136
58. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem J 99 (1966) 667-676
59. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82 1 (2005) 200-206
60. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518 1 (2005) 40-46
61. Zhang F., Altorki N.K., Mestre J.R., Subbaramaiah K., and Dannenberg A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid and phorbol ester treated human gastrointestinal epithelial cells. Carcinogenesis 20 (1999) 445-451